ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

EU MDR and FDA Clinical Evaluation of Medical Device Software and Software as a Medical Device Training Course (ONLINE EVENT: October 1, 2025) - ResearchAndMarkets.com

The "Clinical Evaluation of Medical Device Software and Software as a Medical Device Training Course" training has been added to ResearchAndMarkets.com's offering.

This course will provide a clear understanding of the clinical evaluation requirements and their practical application for software products, including AI/ML-based devices. It will also provide advice on how to determine the type and amount of data needed to sufficiently support the intended medical purpose and (individual) clinical claims, with many practical examples and analysis of differences between the EU MDR and FDA approach.

Whether developing new medical software for more precise diagnosis and targeted treatment or a healthcare app for individuals concerned about their health, manufacturers are tasked to appreciably prove to authorities the safety, quality, and effectiveness of their products.

The evaluation of clinical safety and performance, as well as the overall benefit-risk profile of the product, through a critical assessment of relevant data, is one of the key requirements for the manufacturers of medical device software and a focus area for regulators.

Benefits of attending

  • Gain an in-depth understanding of the requirements for clinical evaluation and how to apply them to different types of medical device software, including AI/ML-based devices
  • Understand how to establish measurable endpoints for clinical claims
  • Find out how to define and generate sufficient clinical and/or performance data to meet the safety and performance requirements of your software device
  • Witness the role of human factors and risks
  • Learn how to retrieve and use literature data effectively
  • Identify residual clinical risks and determine whether post-market clinical follow-up is required
  • Provide robust documentation in support of the clinical safety and performance of your device
  • Hear about frequent pitfalls of clinical regulatory submissions
  • Ensure continuing compliance throughout the software lifecycle

Certifications

  • CPD: 6 hours for your records
  • Certificate of completion

Who Should Attend:

  • Clinical and regulatory affairs professionals
  • Medical software R&D engineers and scientists
  • Product and programme managers
  • Quality assurance professionals

Key Topics Covered:

Introduction to clinical evaluation

  • The regulatory framework of gathering clinical evidence for devices and international differences (EU, US and UK.)
  • Clinical evaluation during the software lifecycle
  • Clinical vs performance evaluation
  • Definitions, purpose, deliverables
  • Process and key characteristics
  • Role of literature and state-of-the-art
  • Selecting data sources
  • Defining acceptance criteria
  • Evaluation of indirect benefits and risks

How to define a scope and a level of clinical evidence for medical device software

  • Validation of clinical association, technical performance and clinical performance
  • Role of validation and usability
  • Considerations for AI/ML - devices

Case studies - clinical evaluation of medical device software

Clinical trials and validation studies

  • Selecting appropriate study design and implications
  • Development and validation of AI/ML devices (cohort, case-control)
  • Clinical performance studies
  • Application of standards
  • Generating evidence of effectiveness
  • Evidence for Health Technology Assessment

Clinical trials and validation studies - continued

  • Reporting guidelines and checklists
  • Challenges of mHealth trials
  • Regulatory and ethical considerations

Clinical evaluation post-market

  • Implementing post-market clinical follow-up for medical device software
  • Real-world evidence

For more information about this training visit https://www.researchandmarkets.com/r/vz7re4

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com



For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.